TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Lifeline Pharma AS
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
18,494
|
19,131
|
31,470 |
| Financial expenses |
810
|
516
|
369 |
| Earnings before taxes |
-1,377
|
839
|
-2,531 |
| Total assets |
16,711
|
13,522
|
15,017 |
| Current assets |
16,087
|
12,931
|
14,492 |
| Current liabilities |
5,579
|
9,374
|
14,605 |
| Equity capital |
-1,634
|
-276
|
-1,406 |
| - share capital |
99
|
106
|
103 |
| Employees (average) |
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-9.8%
|
-2.0%
|
-9.4% |
| Turnover per employee |
6,377
|
10,490 | |
| Profit as a percentage of turnover |
-7.4%
|
4.4%
|
-8.0% |
| Return on assets (ROA) |
-3.4%
|
10.0%
|
-14.4% |
| Current ratio |
288.3%
|
137.9%
|
99.2% |
| Return on equity (ROE) |
84.3%
|
-304.0%
|
180.0% |
| Change turnover |
631
|
-13,314
|
-5,525 |
| Change turnover % |
4%
|
-41%
|
-15% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.